Praxis Medical Insights

Est. 2024 • Clinical Guidelines Distilled

Made possible by volunteer editors from the University of Calgary & University of Alberta

Last Updated: 10/2/2025

Quetiapine Dosing for Tranquilization

Clinical Context and Dosing Strategy

  • The American College of Physicians recommends starting quetiapine at 25 mg orally for acute tranquilization in agitated patients, with dose reduction in elderly or hepatically impaired patients 1, 2, 3
  • For scheduled dosing, administer 25 mg every 12 hours (q12h) if ongoing sedation is needed 1, 2, 3
  • Quetiapine is sedating and has less likelihood of causing extrapyramidal symptoms (EPS) compared to other atypical antipsychotics 1, 2, 3
  • The initial dose for Alzheimer's disease/dementia-related agitation is 12.5 mg twice daily, with a maximum dose of 200 mg twice daily (400 mg/day total) 4, 5

Important Clinical Considerations

  • Quetiapine has sedating properties, making it particularly useful when calming is the primary goal 1, 2, 3, 4, 5
  • It has a lower EPS risk compared to typical antipsychotics and some other atypicals 1, 2, 3
  • Orthostatic hypotension is the most significant acute risk requiring monitoring, particularly with initial doses 1, 2, 3, 4, 5
  • Blood pressure monitoring for orthostasis is necessary, particularly after the first dose 1, 2, 3, 4, 5

Comparison to Alternative Agents

  • Compared to olanzapine, quetiapine has fewer metabolic effects long-term and a lower risk of oversedation when combined with benzodiazepines 1, 2, 3
  • Compared to risperidone, quetiapine has a lower EPS risk and does not cause prolactin elevation 1, 2, 3